Cybin Inc. (OTCMKTS:CLXPF - Get Free Report) shares shot up 0.4% during mid-day trading on Thursday . The stock traded as high as $8.00 and last traded at $7.76. 428,944 shares were traded during trading, a decline of 22% from the average session volume of 551,962 shares. The stock had previously closed at $7.73.
Cybin Trading Down 0.6%
The firm has a market cap of $1.19 billion and a price-to-earnings ratio of -33.29. The stock has a fifty day moving average price of $7.96 and a 200 day moving average price of $7.85.
About Cybin
(
Get Free Report)
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
Further Reading
Before you consider Cybin, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cybin wasn't on the list.
While Cybin currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
